Characterization and standardization of multiassay platforms for four commonly studied traumatic brain injury protein biomarkers: a TBI Endpoints Development Study

Conclusion: Due to the variability of TBI marker assay in performance and reported values, standardization strategies are recommended when comparing reported biomarker levels across assay platforms.PMID:34674546 | DOI:10.2217/bmm-2021-0284

Source: Future Medicine: Biomarkers in Medicine - October 22, 2021 Category: Internal Medicine Authors: George Anis Sarkis Tian Zhu Zhihui Yang Xue Li Yuan Shi Richard Rubenstein Richard A Yost Geoffrey T Manley Kevin K Wang Source Type: research